A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

计划入组 2 人 · 首次发布于 2006 年 6 月 22 日

ESWL for Distal Ureteric Stone: Supine Versus Prone

计划入组 130 人 · 首次发布于 2014 年 11 月 24 日

A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.

计划入组 400 人 · 首次发布于 2005 年 11 月 7 日

ApTOLL

Apoptone

C₂₁H₃₂O₂

Dapsone(Aczone)

C₁₂H₁₂N₂O₂S · Rx

Capstone Nutrition, LLC

United States

CAPSTONE THERAPEUTICS CORP.

United States

CENTRE ANTOINE LACASSAGNE

France

Aptone Finalizes FDA Phase 3 Protocol for Orphan Drug GPC-100, a Rapid-Acting Stem Cell Mobilizer

Aptose Biosciences' Tuspetinib Shows Promise in AML Triplet Therapy, Receives $10M Loan from Hanmi

Aptose and NCI Partner to Advance Tuspetinib in AML and MDS Trials